By producing metformin inputs in-house, Aarti Drugs cut costs and helped lift Q2 net profit 83% to...

By producing metformin inputs in-house, Aarti Drugs cut costs and helped lift Q2 net profit 83% to ₹82.8 crore.

If you manage pharma sourcing, backward integration by API makers is helping reduce costs and secure anti-diabetic medicine supplies.

https://ehealth.eletsonline.com/2026/11/aarti-drugs-q2-fy27-results/